Genomics

Dataset Information

0

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2-positive breast cancer in the adaptively randomized I-SPY2 trial.


ABSTRACT: Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2-positive breast cancer in the adaptively randomized I-SPY2 trial.

PROVIDER: PRJNA753123 | ENA |

REPOSITORIES: ENA

Similar Datasets

2021-08-24 | GSE181574 | GEO
2020-01-26 | GSE121105 | GEO
| S-EPMC8571284 | biostudies-literature
| PRJNA495653 | ENA
2020-03-05 | GSE146380 | GEO
2012-05-02 | E-GEOD-31432 | biostudies-arrayexpress
2019-12-31 | GSE89216 | GEO
2022-11-04 | GSE122426 | GEO
2018-04-01 | GSE109710 | GEO
2012-05-03 | GSE31432 | GEO